# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Dwight D. Eisenhower (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET015-SYN-TD
- Date: 1956-09-28
- Fictional facility: St. Posthumous Health Center
- Fictional author: Russell Okonkwo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

One-year review after myocardial infarction. **S**

## History of present illness

Mr. Eisenhower returns one year after his myocardial infarction. He has had no chest pain, breathlessness, palpitations, or bleeding, and has not needed nitroglycerin. He works full time, travels, and plays golf twice a week. He did not get the basic metabolic panel ordered for July because he was travelling. He asks whether he can now stop ticagrelor, which bruises him, and whether he still needs metoprolol. **S**

| Element | Detail |
|---|---|
| Interval change | No angina, bleeding, or nitroglycerin use |
| Function | Full-time work, travel, and golf |
| Missed test | Basic metabolic panel due in July not drawn |
| Patient questions | Stopping ticagrelor and metoprolol |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Good energy; weight stable |
| Cardiovascular | Negative | No chest pain, palpitations, or edema |
| Respiratory | Negative | No breathlessness |
| Hematologic | Positive | Easy forearm bruising; no nosebleeds or other bleeding |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |

5 systems reviewed. **S**

## Current medications

- Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth daily **S**
- Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily **S**
- Lisinopril 10 mg oral tablet, one tablet by mouth daily **S**
- Ezetimibe 10 mg oral tablet, one tablet by mouth daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tablet **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/74 mmHg; pulse 60 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 77 kg; BMI 24.3 kg/m². All vital signs are synthetic.

Total cholesterol: 116 mg/dL; HDL cholesterol: 45 mg/dL; Triglycerides: 110 mg/dL; LDL cholesterol: 49 mg/dL; Sodium: 140 mmol/L; Potassium: 4.5 mmol/L; Creatinine: 1.02 mg/dL; eGFR: 82 mL/min/1.73 m²; Glucose: 95 mg/dL; PHQ-2: 0. All results are synthetic.

## Change since baseline

- Total cholesterol: 150 mg/dL at baseline, 116 mg/dL at this visit **S**
- HDL cholesterol: 42 mg/dL at baseline, 45 mg/dL at this visit **S**
- Triglycerides: 150 mg/dL (high) at baseline, 110 mg/dL at this visit **S**
- LDL cholesterol: 78 mg/dL at baseline, 49 mg/dL at this visit **S**
- Sodium: 140 mmol/L at baseline, 140 mmol/L at this visit **S**
- Potassium: 4.4 mmol/L at baseline, 4.5 mmol/L at this visit **S**
- Creatinine: 1 mg/dL at baseline, 1.02 mg/dL at this visit **S**
- eGFR: 84 mL/min/1.73 m² at baseline, 82 mL/min/1.73 m² at this visit **S**
- Glucose: 96 mg/dL at baseline, 95 mg/dL at this visit **S**
- PHQ-2: 1 at baseline, 0 at this visit **S**

## Immunizations given today

- Respiratory syncytial virus vaccine, single dose **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Skin | Small bruises on both forearms |
| Heart | Regular rhythm at 60; no murmur or gallop |
| Lungs | Clear |
| Extremities | No edema |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Myocardial infarction one year ago** (I25.2). Twelve months of dual antiplatelet therapy completed without major bleeding. **S**
   - Stop ticagrelor today; continue aspirin 81 mg daily for life.
   - Continue metoprolol succinate 25 mg daily: his ejection fraction recovered to 52 percent, so the beta-blocker is now continued for his hypertension and blood pressure control, which are good on it.
2. **Hyperlipidemia** (E78.5). LDL cholesterol 49 mg/dL, at goal. **S**
   - Continue atorvastatin and ezetimibe; lipid panel yearly.
3. **Essential hypertension** (I10). Blood pressure 124/74 mmHg. Potassium 4.5 and eGFR 82 on lisinopril. **S**
   - No change; basic metabolic panel every six months, with a reminder.
4. **Former heavy cigarette smoker** (Z87.891). Abstinent about seven years. **S**
   - Discuss lung cancer and abdominal aortic aneurysm screening at next month's annual wellness visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Medication safety | Dual antiplatelet therapy duration | At least 12 months after an acute coronary syndrome, then aspirin alone | Completed today | Twelve months completed without major bleeding; ticagrelor stopped today, aspirin continued |
| Medication safety | Beta-blocker review | Reassess one year after the infarction | Completed today | Continued for hypertension; LVEF 52 percent and no angina or arrhythmia |
| Laboratory | Lipid panel | 4 to 12 weeks after starting or changing therapy, then every 3 to 12 months | Completed today | LDL cholesterol 49 mg/dL on atorvastatin and ezetimibe, at goal |
| Laboratory | Basic metabolic panel | 1 to 2 weeks after starting or changing an ACE inhibitor, then every 6 months | Completed today | Potassium 4.5, creatinine 1.02 mg/dL, eGFR 82 |
| Laboratory | Basic metabolic panel six months after the last | Every 6 months on an ACE inhibitor | Deferred | Due in July and ordered at the last visit, but not drawn while he was travelling: a deviation from the protocol. Today's potassium and kidney function are normal, so no harm resulted. Corrective action: a laboratory reminder is now set for each six-month draw |
| Examination | Blood pressure, heart rate, weight and BMI, heart and lungs, edema | Every visit | Completed today | Blood pressure 124/74 mmHg, heart rate 60, weight 77.0 kg |
| Survey | Depression screen (PHQ-2) | Every visit | Completed today | Score 0 |
| Self-management | Tobacco use | Every visit | Completed today | Abstinent |
| Medication safety | Influenza, COVID-19, and RSV vaccination | Yearly influenza; others on the CDC schedule | Completed today | RSV vaccine given today; influenza and COVID-19 vaccines planned at next month's wellness visit |
| Laboratory | HbA1c | Yearly diabetes screen with hypertension | Up to date | 5.6% in January; due in January |

## Goal progress

- Lower LDL cholesterol below 55 mg/dL by the lipid recheck in about two months. Outcome by 1956-03-16: LDL cholesterol 50 mg/dL on atorvastatin and ezetimibe. **S**
- Keep blood pressure below 130/80 mmHg. Outcome by 1956-03-16: Blood pressure 124/76 mmHg on lisinopril 10 mg and metoprolol. **S**
- Return to full-time work and travel by the seven-month review. Outcome by 1956-05-11: Full-time work since late January; travelling again. **S**
- Keep at least 150 minutes a week of moderate exercise after cardiac rehabilitation. Outcome by 1956-05-11: Brisk walking most days and golf twice a week. **S**
- Complete twelve months of dual antiplatelet therapy without major bleeding. Outcome by 1956-09-28: Ticagrelor stopped at one year; one minor anterior nosebleed only. **S**

## Medication changes

- Stopped: Ticagrelor 90 mg oral tablet, one tablet by mouth twice daily **S**

## Guideline basis

- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025), American College of Cardiology and American Heart Association
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023), American Heart Association and American College of Cardiology
- CMID: Clinical Monitoring Intelligence Database, acute myocardial infarction, ischemic heart disease, hyperlipidemia, and hypertension monographs (2026), Aether Forge

## Follow-up

- Annual wellness visit next month. Coronary review with a lipid panel and basic metabolic panel in about six months. **S**
- Next scheduled visit 1956-10-19: initial annual wellness visit. **S**
